North America Platelet Rich Plasma Market, By Type (Pure Platelet Rich Plasma, Leukocyte-Rich Platelet Rich Plasma, Leukocyte-Rich Fibrin, Others), Origin (Allogeneic Platelet Rich Plasma, Autologous Platelet Rich Plasma, Homologous Platelet Rich Plasma), Application (Cosmetic Surgery and Aesthetics, General Surgery, Neurosurgery, Orthopedic and Spinal Surgery, Others), End User (Hospitals and Clinics, Research Institutes, Others), Country (U.S., Mexico, Canada) Industry Trends and Forecast to 2028.
Market Analysis and Insights : North America Platelet Rich Plasma Market
Data Bridge Market Research analyses that the North America platelet rich plasma market to be growing at CAGR of 13.8% in the forecast period of 2021-2028 and is expected to reach USD 258.14 million by 2028.
Platelet rich plasma is endogenous plasma which is ideal for platelets and isolated from whole blood. Although PRP is a major component of platelets, other cellular components such as white blood cells (WBC) and peripheral stem cells may also be involved in the preparation. These are all biochemical components in drugs and are used at high levels of PRP. Therefore, PRP can help optimize the healing environment for bones and soft tissues.
The growing geriatric population and surge in the number of cosmetic surgery procedures are the major factors influencing the growth of the platelet-rich plasma market. Furthermore, growing incidences of sport and orthopedic accidents, increasing awareness about PRP treatments, and the rise in the benefits of using traditional prefilled syringes are the major fostering that will enhance the growth of the platelet-rich plasma market.
Technological advancement and emerging new markets will provide beneficial opportunities for the market growth.
However, high volatilization in the price of platelet-rich plasma therapy and favourable reimbursement policies in wound care devices are the factors that will obstruct the market growth. Problems with quality control and test results will challenge the platelet rich plasma market.
North America platelet rich plasma market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on North America platelet rich plasma market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
North America Platelet Rich Plasma Market Scope and Market Size
North America platelet rich plasma market is segmented on the basis of type, origin, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
The platelet rich plasma market is segmented on the basis of type into pure platelet rich plasma, leukocyte-rich platelet rich plasma, leukocyte-rich fibrin and others.
- On the basis of origin, the platelet rich plasma market is segmented into allogeneic platelet rich plasma, autologous platelet rich plasma and homologous platelet rich plasma.
- On the basis of application, the platelet rich plasma market is segmented into cosmetic surgery and aesthetics, general surgery, neurosurgery, orthopedic and spinal surgery and others. Others have been further sub-segmented into urology, cardiothoracic surgery, oral and maxillofacial surgery, periodontal surgery, otorhinolaryngology-head and neck surgery.
- On the basis of end user, the platelet rich plasma market is segmented into hospitals, and clinics, research institutes and others.
North America Platelet Rich Plasma Market Country Level Analysis
North America platelet rich plasma market is analysed and market size insights and trends are provided by country, type, origin, application and end user as referenced above.
The countries covered in North America platelet rich plasma market report are U.S., Canada and Mexico.
United States dominates the North America platelet rich plasma market during the forecast period of 2021-2028 due to the growing prevalence of chronic disorders and rising demand for cosmetic surgeries.
The country section of the North America platelet rich plasma market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
North America platelet rich plasma market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America platelet rich plasma market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America platelet rich plasma market. The data is available for historic period 2010 to 2019.
Competitive Landscape and North America Platelet Rich Plasma Market Share Analysis
North America platelet rich plasma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to North America platelet rich plasma market.
The major players covered in the North America platelet rich plasma market report are Ycellbio Medical Co., Ltd., Cytomedix, Inc. New, Zimmer Biomet, Stryker, Rocky Mountain Biologicals, Regen Lab SA, TERUMO BCT, INC., Glofinn Oy, Exatech, Inc., EmCyte Corporation, Medical Devices Business Services, Inc., ThermoGenesis Holdings, Inc., Octapharma Brasil Ltda, DR PRP USA LLC, Isto Biologics, Arthrex, Inc., Terumo Corporation, Cascade Medical, Grifols, S.A., among other. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-